文献速递脑血管病

R-tPA抵抗对富血小板卒中血栓具有特异性,可通过靶向非纤维蛋白成分克服

R-tPA Resistance Is Specific for Platelet-Rich Stroke Thrombi and Can Be Overcome by Targeting Nonfibrin Components.
PubMed 文献 · Stroke · 2024-03-25

研究将急性缺血性卒中患者血栓分为两部分,分别用于溶栓和详细组织学分析,在正常人血浆中单独使用r-tPA、r-tPA联合DNase-1或r-tPA联合N,N'-二乙酰-L-胱氨酸进行溶栓。结果显示,r-tPA溶栓效果与血栓成分强相关:富含红细胞且DNA和血管性血友病因子含量低的血栓可被r-tPA有效降解,而红细胞少且DNA和血管性血友病因子含量高的血栓对r-tPA抵抗;r-tPA联合DNase-1或N,N'-二乙酰-L-胱氨酸可显著且特异性地改善这些r-tPA抵抗血栓的溶解。

要点

  • r-tPA溶栓效果与卒中血栓成分强相关。
  • 红细胞少且DNA和血管性血友病因子高的血栓对r-tPA抵抗。
  • r-tPA联合DNase-1或N,N'-二乙酰-L-胱氨酸可显著且特异性地改善抵抗血栓的溶解。

核心结论

  • 利用患者血栓材料首次表明,卒中血栓成分在很大程度上决定其对r-tPA介导溶栓的易感性。
  • 红细胞少的血栓对r-tPA具有特异性抵抗,可通过DNase-1或N,N'-二乙酰-L-胱氨酸靶向非纤维蛋白成分来克服。

研究设计与样本

  • 使用急性缺血性卒中患者的临床相关血栓,将每份血栓分为两部分,一部分用于溶栓,另一部分用于详细组织学分析。
  • 溶栓在正常人血浆中进行,分别采用单独r-tPA、r-tPA联合DNase-1或r-tPA联合N,N'-二乙酰-L-胱氨酸。
  • 血栓溶解程度以残余血栓重量占初始重量的百分比计算,并与组织学确定的血栓成分相关联。

主要发现

  • r-tPA介导的溶栓效果与血栓成分强相关。
  • 富含红细胞且DNA和血管性血友病因子含量低的血栓可被r-tPA有效降解。
  • 红细胞少且DNA和血管性血友病因子含量较高的血栓对r-tPA抵抗。
  • r-tPA联合DNase-1或N,N'-二乙酰-L-胱氨酸可显著且特异性地改善这些r-tPA抵抗血栓的溶解。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Resistance to r-tPA (recombinant tissue-type plasminogen activator) is a well-known but poorly understood phenomenon that hampers successful recanalization in patients with acute ischemic stroke. Using clinically relevant thrombi from patients with acute ischemic stroke, we investigated if and how thrombus composition impacts r-tPA-mediated lysis. In addition, we explored strategies to overcome r-tPA resistance. METHODS: Thrombi were split into 2 parts, 1 of which was used for thrombolysis and the other for detailed histological analysis. Thrombolysis was performed in normal human plasma using r-tPA alone, using r-tPA in combination with DNase-1 or using r-tPA in combination with N,N'-diacetyl-l-cystine. Thrombus lysis was calculated as the percentage of residual thrombus weight compared with its initial weight and the degree of lysis was linked to thrombus composition determined via histology. RESULTS: Interestingly, we found that the efficacy of r-tPA-mediated thrombolysis was strongly correlated with the composition of the thrombi. Thrombi containing high amounts of red blood cells and low amounts of DNA and von Willebrand Factor were efficiently degraded by r-tPA, whereas thrombi containing low amounts of red blood cells and higher amounts of DNA and von Willebrand Factor were resistant to r-tPA. Importantly, combination of r-tPA with DNase-1 or N,N'-diacetyl-l-cystine significantly and specifically improved the lysis of these r-tPA-resistant thrombi. CONCLUSIONS: Using patient thrombus material, our results for the first time show that the composition of stroke thrombi largely determines their susceptibility to r-tPA-mediated thrombolysis. Red blood cell-poor thrombi have a specific resistance to r-tPA, which can be overcome by targeting nonfibrin components using DNase-1 or N,N'-diacetyl-l-cystine.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Vandelanotte S, François O, Desender L, et al. R-tPA Resistance Is Specific for Platelet-Rich Stroke Thrombi and Can Be Overcome by Targeting Nonfibrin Components. Stroke. 2024. PMID: 38525646. doi:10.1161/STROKEAHA.123.045880

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。